TABLE 4.
Sequelaea | <2 y (n = 39) | 2–9 y (n = 11) | 10–17 y (n = 9) |
---|---|---|---|
Severe developmental delay | 18 (46) | 4 (36) | 1 (13) |
Sensorineural hearing loss | 15 (38) | 2 (18) | 0 (0) |
Persistent seizures at 1 year | 13 (33) | 6 (55) | 0 (0) |
Cochlear implant | 9 (23) | 2 (18) | 0 (0) |
Cranial nerve palsy | 9 (23) | 3 (27) | 2 (22) |
Hydrocephalus | 8 (21) | 0 (0) | 0 (0) |
Quadriplegia | 7 (18) | 0 (0) | 0 (0) |
Cortical blindness | 6 (15) | 1 (9) | 0 (0) |
Hemiparesis | 4 (10) | 1 (9) | 2 (22) |
Ataxia | 2 (5) | 2 (18) | 1 (13) |
Hyperactivity | 2 (5) | 2 (18) | 0 (0) |
Microcephaly | 2 (5) | 0 (0) | 0 (0) |
Any neurologic sequelae, including hearing loss and/or behavioral impairment | 26 (67) | 8 (73) | 3 (33) |
Data are presented as n (%).
Calculated for survivors only (n = 59).
Neurologic sequelae were diagnosed at discharge and/or follow-up.